Evidence map›Paper›PMID 34457742›Full record

ArticleMedical science educator2020

A Qualitative Assessment of Current Pharmacovigilance Education in Lebanese Pharmacy Schools.

Anas Bahnassi

Open access · greenAbstract read
In one paragraph

Article in Medical science educator, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Anas BahnassiFoundational Reset Ambassador, Rexall Pharmacy Limited, McKesson Canada, Ottawa, ON Canada.ORCID https://orcid.org/0000-0003-2371-3663
McKesson (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to explore faculty opinions and views regarding pharmacovigilance content in courses taught to pharmacy students in Lebanese universities.

methodsThis study identified faculty from all five universities providing pharmacy programs in Lebanon. Participants were identified through the universities' websites. After obtaining required consents, fourteen interviews were conducted and transcribed. All interviews followed a previously prepared and validated interview theme guide.

resultsFourteen professors participated in the study. Qualitative analysis revealed four themes with regard to participants' knowledge of the pharmacovigilance content and their students' competency in applying pharmacovigilance concepts in their practice. The emerged themes were identified as follows: limited pharmacovigilance content in current pharmacy schools' curricula, the need to include pharmacovigilance competencies in practical courses and experiential training, plans to strengthen the pharmacovigilance content in pharmacy schools, and the implication of providing adequate pharmacovigilance competencies on the success of the proposed national pharmacovigilance program in the country.

conclusionPharmacovigilance content in pharmacy programs is still inadequate. Our study participants believed that this limited content may overall undermine patient safety. It was thought that preparing pharmacy graduates to undertake pharmacovigilance tasks through providing early didactic teaching of pharmacovigilance concepts, integrating pharmacovigilance competencies into experiential training, providing graduate pharmacovigilance courses, and continuing professional education in topics of pharmacovigilance will improve the level of pharmacy professional practice and patient safety and encourage proper implantation of the national pharmacovigilance program in this country.

Indexed as

Adverse drug reactionsLebanonPatient safetyPharmacovigilancePharmacy education

Identifiers

PMID34457742
PMCPMC8368960
OpenAlexW3019909189

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.